In addition, we also found that the expression of MYC was upregulated (Fig. 6B), while p21 and BIM were downregulated in clinical EMC samples compared to the adjacent normal tissue (Fig. 6C). The gene discussed is CDKN1A; the disease is extraskeletal myxoid chondrosarcoma.